Tight Glycemic Control Reduces Heart Inflammation and Remodeling During Acute Myocardial Infarction in Hyperglycemic Patients

Journal of the American College of Cardiology

Volumn 53, Issue 16, 2009, Pages 1425-1436

  Marfella, Raffaele ^a   Di Filippo, Clara ^a   Portoghese, Michele ^b   Ferraraccio, Franca ^a   Rizzo, Maria Rosaria ^a   Siniscalchi, Mario ^c   Musacchio, Emilio ^d   D'Amico, Michele ^a   Rossi, Francesco ^a   Paolisso, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Sassari Hospital   (Italy)

^c Agropoli Hospital   (Italy)

^d Cardarelli Hospital   (Italy)

Author keywords

apoptosis; glycemic control; inflammation; myocardial infarction; remodeling

Indexed keywords

3 NITROTYROSINE; CASPASE 3; GLUCOSE; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCOMPONENT INSULIN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; APOPTOSIS; ARTICLE; CARDITIS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLYCEMIC CONTROL; HEART EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART PERFORMANCE; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; TREATMENT OUTCOME;

BLOOD GLUCOSE; CORONARY ARTERY BYPASS; FEMALE; HUMANS; HYPERGLYCEMIA; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; VENTRICULAR REMODELING;

EID: 64049089886     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.01.041     Document Type: Article

References (34)

1. Cruikshank N. Coronary thrombosis and myocardial infarction with glycosuria. BMJ 1 (1931) 618-619
2. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
3. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
4. Deedwania P., Kosiborod M., Barrett E., et al., American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117 (2008) 1610-1619
5. Nian M., Lee P., Khaper N., and Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94 (2004) 1543-1553
6. Marfella R., Siniscalchi M., Esposito K., et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 26 (2003) 3129-3135
7. Marfella R., Di Filippo C., Esposito K., et al. Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice. Diabetes 53 (2004) 454-462
8. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
9. Goldberg P.A., Siegel M.D., Sherwin R.S., et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27 (2004) 461-467
10. Jolliet P., Pichard C., Biolo G., et al. Enteral nutrition in intensive care patients: a practical approach: Working Group on Nutrition and Metabolism, ESICM: European Society of Intensive Care Medicine. Intensive Care Med 824 (1998) 848-859
11. Gardin J.M., Adams D.B., Douglas P.S., et al. American Society of Echocardiography: recommendations for a standardized report for adult transthoracic echocardiography. J Am Soc Echocardiogr 15 (2002) 275-290
12. Marfella R., D'Amico M., Di Filippo C., et al. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. J Am Coll Cardiol 47 (2006) 2444-2455
13. Ohlsson B.G., Englund M.C.O., Karlsson A.L.K., et al. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages. J Clin Invest 98 (1996) 78-89
14. Poulsen S.H., Jensen S.E., Tei C., et al. Value of the Doppler index of myocardial performance in the early phase of acute myocardial infarction. J Am Soc Echocardiogr 13 (2000) 723-730
15. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., and Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85 (2000) 2970-2973
16. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 71 (1996) C1424-C1437
17. Frustaci A., Kajstura J., Chimenti C., et al. Myocardial cell death in human diabetes. Circ Res 87 (2000) 1123-1132
18. Ceriello A., Quagliaro L., D'Amico M., et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat diabetes. Diabetes 51 (2002) 1076-1082
19. Arstall M.A., Sawyer D.B., Fukazawa R., et al. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 85 (1999) 829-840
20. Kaminski K.A., Bonda T.A., Korecki J., et al. Oxidative stress and neutrophil activation-the two keystones of ischemia/reperfusion injury. Int J Cardiol 86 (2002) 41-59
21. Thoenes M., Forstermann U., Tracey W.R., et al. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 28 (1996) 165-169
22. Cheung N.W., Wong V.W., and McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29 (2006) 765-770
23. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59 (2000) 13-23
24. Aljada A., Friedman J., Ghanim H., et al. Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism 55 (2006) 1177-1185
25. Dandona P., Aljada A., Mohanty P., et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 86 (2001) 3257-3265
26. Chaudhuri A., Janicke D., Wilson M.F., et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 109 (2004) 849-854
27. Zhang H.X., Zang Y.M., Huo J.H., et al. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J Cardiovasc Pharmacol 48 (2006) 306-313
28. Kwoun M.O., Ling P.R., Lydon E., et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 21 (1997) 91-95
29. Morisco C., Marrone C., Trimarco V., et al. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression. Cardiovasc Res 76 (2007) 453-464
30. Opie L.H. Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia. Circulation 117 (2008) 2172-2177
31. Malmberg K., Rydén L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
32. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
33. van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
34. Díaz R., Goyal A., Mehta S.R., et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA 298 (2007) 2399-2405